Global Legal Chronicle covered life sciences partner Kathleen Kean joining Morrison Foerster in its Boston office. Kathleen brings more than 20 years of combined private practice and in-house experience advising biotechnology, pharmaceutical, diagnostics, and medical device companies on complex licensing, commercialization, and multibillion-dollar collaboration and M&A-adjacent transactions.
She said, “Morrison Foerster is a life sciences and technology industry leader with a tremendous global platform and transactional capabilities. I am thrilled at the prospect of growing my practice on the ground in Boston’s thriving market and collaborating with my new colleagues across the firm’s offices to help our life sciences and biotech clients solve their most complex, cutting-edge transactions and licensing matters.”
Read the full article.